CompletedNCT01013311

Implantable Cardiac Defibrillators for the Prevention of Sudden Death in Patients With Cardiac Sarcoidosis

Studying Sarcoidosis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Virginia Commonwealth University
Principal Investigator
Kenneth A Ellenbogen, MD
Virginia Commonweath University
Enrollment
10 target
Eligibility
18 years · All sexes
Timeline
2009 – 2010

Study locations (1)

Collaborators

Stanford University · Icahn School of Medicine at Mount Sinai · Weill Medical College of Cornell University · The Cleveland Clinic

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01013311 on ClinicalTrials.gov

Other trials for Sarcoidosis

Additional recruiting or active studies for the same condition.

See all trials for Sarcoidosis →

← Back to all trials